IL-1β and IL-17A are known to negatively regulate Regnase-1 [18, 19] and we found significant upregulation of IL-1β but did not detect IL-17A expression in the tumor sites (Fig. 5H, Supplementary Fig. 8). This evidence concerns the gene IL17A and neoplasm.